Skip to main content

Animations

MJFF Publications

5251 - 5260 of 8808 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2021
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Untwisted α-Synuclein Filaments Formed in the Presence of Lipid Vesicles
    Journal Name: Biochemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.biochem.2c00283
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Library-Derived Peptide Aggregation Modulators of Parkinson’s Disease Early-Onset α-Synuclein Variants
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acschemneuro.2c00190
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s Disease
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.2c01605
    Citation Count: 17
  • Summary Details
    OPEN
    Title: How Prolonged Isolation Affects People With Parkinson Disease During the COVID-19 Pandemic
    Journal Name: JAMA
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jama.2022.1510
    Citation Count: 6
  • Summary Details
    RESTRICTED
    Title: Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease—Reply
    Journal Name: JAMA
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jama.2021.21011
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease
    Journal Name: JAMA
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jama.2021.21008
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Error in Figure
    Journal Name: JAMA
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jama.2021.16187
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK Population
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.0003
    Citation Count: 64
  • Summary Details
    OPEN
    Title: Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.0676
    Citation Count: 56
  • Summary Details
    OPEN
    Title: Association of Plasma and Cerebrospinal Fluid Alzheimer Disease Biomarkers With Race and the Role of Genetic Ancestry, Vascular Comorbidities, and Neighborhood Factors
    Journal Name: JAMA Network Open
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1001/jamanetworkopen.2022.35068
    Citation Count: 50
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.